Home Healthcare Biotechnology Antibodies Market

Antibodies Market Size, Share & Trends Analysis Report By Type (Monoclonal Antibodies, Polyclonal Antibodies, Antibody Drug Conjugates), By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Neurological Diseases, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR6566DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Antibodies Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Monoclonal Antibodies
    2. Polyclonal Antibodies
    3. Antibody Drug Conjugates
  2. Antibodies Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Autoimmune Diseases
    3. Infectious Diseases
    4. Neurological Diseases
    5. Others
  3. Regional Antibodies Market
    1. North America
      1. North America Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Polyclonal Antibodies
        3. Antibody Drug Conjugates
      2. North America Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Infectious Diseases
        4. Neurological Diseases
        5. Others
      3. U.S. Antibodies Market
        1. U.S. Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. U.S. Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      4. Canada Antibodies Market
        1. Canada Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Canada Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
    2. Europe
      1. Europe Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Polyclonal Antibodies
        3. Antibody Drug Conjugates
      2. Europe Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Infectious Diseases
        4. Neurological Diseases
        5. Others
      3. U.K. Antibodies Market
        1. U.K. Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. U.K. Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      4. Germany Antibodies Market
        1. Germany Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Germany Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      5. France Antibodies Market
        1. France Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. France Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      6. Spain Antibodies Market
        1. Spain Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Spain Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      7. Italy Antibodies Market
        1. Italy Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Italy Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      8. Russia Antibodies Market
        1. Russia Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Russia Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      9. Nordic Antibodies Market
        1. Nordic Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Nordic Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      10. Benelux Antibodies Market
        1. Benelux Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Benelux Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      11. Rest of Europe Antibodies Market
        1. Rest of Europe Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Rest of Europe Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
    3. APAC
      1. APAC Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Polyclonal Antibodies
        3. Antibody Drug Conjugates
      2. APAC Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Infectious Diseases
        4. Neurological Diseases
        5. Others
      3. China Antibodies Market
        1. China Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. China Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      4. Korea Antibodies Market
        1. Korea Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Korea Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      5. Japan Antibodies Market
        1. Japan Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Japan Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      6. India Antibodies Market
        1. India Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. India Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      7. Australia Antibodies Market
        1. Australia Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Australia Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      8. Taiwan Antibodies Market
        1. Taiwan Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Taiwan Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      9. South East Asia Antibodies Market
        1. South East Asia Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. South East Asia Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      10. Rest of Asia-Pacific Antibodies Market
        1. Rest of Asia-Pacific Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Rest of Asia-Pacific Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
    4. Middle East and Africa
      1. Middle East and Africa Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Polyclonal Antibodies
        3. Antibody Drug Conjugates
      2. Middle East and Africa Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Infectious Diseases
        4. Neurological Diseases
        5. Others
      3. UAE Antibodies Market
        1. UAE Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. UAE Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      4. Turkey Antibodies Market
        1. Turkey Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Turkey Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      5. Saudi Arabia Antibodies Market
        1. Saudi Arabia Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Saudi Arabia Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      6. South Africa Antibodies Market
        1. South Africa Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. South Africa Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      7. Egypt Antibodies Market
        1. Egypt Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Egypt Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      8. Nigeria Antibodies Market
        1. Nigeria Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Nigeria Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      9. Rest of MEA Antibodies Market
        1. Rest of MEA Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Rest of MEA Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
    5. LATAM
      1. LATAM Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Polyclonal Antibodies
        3. Antibody Drug Conjugates
      2. LATAM Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Infectious Diseases
        4. Neurological Diseases
        5. Others
      3. Brazil Antibodies Market
        1. Brazil Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Brazil Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      4. Mexico Antibodies Market
        1. Mexico Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Mexico Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      5. Argentina Antibodies Market
        1. Argentina Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Argentina Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      6. Chile Antibodies Market
        1. Chile Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Chile Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      7. Colombia Antibodies Market
        1. Colombia Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Colombia Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
      8. Rest of LATAM Antibodies Market
        1. Rest of LATAM Antibodies Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monoclonal Antibodies
          2. Polyclonal Antibodies
          3. Antibody Drug Conjugates
        2. Rest of LATAM Antibodies Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Autoimmune Diseases
          3. Infectious Diseases
          4. Neurological Diseases
          5. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.